These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

276 related items for PubMed ID: 6979006

  • 1. [Clinico-microbiologic bases for the use of new cephalosporins].
    De Bac C, Mascellino MT, Nuti M.
    Minerva Med; 1982 Apr 07; 73(15):899-903. PubMed ID: 6979006
    [No Abstract] [Full Text] [Related]

  • 2. Comparative in-vitro activity of cefamandole, cefoxitin, cefuroxime and cephalothin.
    Brorson JE, Norrby R.
    Scand J Infect Dis Suppl; 1978 Apr 07; (13):88-93. PubMed ID: 278150
    [No Abstract] [Full Text] [Related]

  • 3. The effect of beta-lactamase stability, penetration, and target affinity on the activity of cefazolin, cefamandole, cefoxitin, and cefuroxime.
    Harper PB.
    Clin Ther; 1984 Apr 07; 6(3):310-24. PubMed ID: 6609771
    [Abstract] [Full Text] [Related]

  • 4. [Activity of new cephalosporins against polyresistant bacterial strains].
    De Toffoli A, Fantin B.
    Minerva Med; 1983 Mar 10; 74(9-10):427-31. PubMed ID: 6300736
    [Abstract] [Full Text] [Related]

  • 5. [3 new cephalosporins: cefamandole, cefuroxime, cefoxitin].
    Mirimanoff RO, Héraïef E.
    Rev Med Suisse Romande; 1981 Dec 10; 101(12):963-8. PubMed ID: 7342276
    [No Abstract] [Full Text] [Related]

  • 6. ["In vitro" activity of cefamandole, cefalotin, cefoxitin and cefuroxim against enterobacteria and Staphylococcus aureus isolated in hospital (author's transl)].
    Thabaut A, Durosoir JL, Saliou P.
    Pathol Biol (Paris); 1979 Dec 10; 27(10):649-54. PubMed ID: 395496
    [Abstract] [Full Text] [Related]

  • 7. [Minimal inhibitory and bactericidal concentrations of cefoperazone, cefotaxime, cefuroxime and cefalotin against 90 bacterial strains].
    Mascellino MT, Prignano G, Iegri F, Lorenzi A.
    Boll Ist Sieroter Milan; 1982 Dec 10; 61(4):309-19. PubMed ID: 6100234
    [Abstract] [Full Text] [Related]

  • 8. Comparative activity of two newer cephalosporins, cefoxitin, and cephalothin against selected Enterobacteriaceae and correlation with enzymatic resistance mechanisms.
    Vuye A, Pijck J, Van Landuyt HW.
    J Antimicrob Chemother; 1979 May 10; 5(3):293-300. PubMed ID: 314440
    [No Abstract] [Full Text] [Related]

  • 9. Cefuroxime, cefamandole, cefoxitin, and cephalothin in vitro susceptibility tests: reassessment of the "class representative" concept, confirmation of disk interpretive criteria, and proposed quality control guidelines.
    Barry AL, Jones RN, Thornsberry C.
    Am J Clin Pathol; 1983 Aug 10; 80(2):182-9. PubMed ID: 6881092
    [Abstract] [Full Text] [Related]

  • 10. [Antibacterial activity of cefotaxim in comparison with seven cephalosporins].
    Braveny I, Dickert H, Machka K.
    Infection; 1979 Aug 10; 7(5):231-6. PubMed ID: 389804
    [Abstract] [Full Text] [Related]

  • 11. Antibacterial activity of five cephalosporins.
    Mutton KJ, Harkness JL.
    Pathology; 1981 Jan 10; 13(1):73-7. PubMed ID: 6784093
    [Abstract] [Full Text] [Related]

  • 12. Susceptibility of cephalothin-resistant gram-negative bacilli to piperacillin, cefuroxime, and other selected antibiotics.
    George WL, Lewis RP, Meyer RD.
    Antimicrob Agents Chemother; 1978 Mar 10; 13(3):484-9. PubMed ID: 122524
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Cefoxitin, a new beta-lactamase stable antibiotic].
    Simon C, Meyer E, Malerczyk.
    Arzneimittelforschung; 1978 Mar 10; 28(9):1541-5. PubMed ID: 314296
    [No Abstract] [Full Text] [Related]

  • 15. Emergence of resistance to cefamandole: possible role of cefoxitin-inducible beta-lactamases.
    Sanders CC, Sanders WE.
    Antimicrob Agents Chemother; 1979 Jun 10; 15(6):792-7. PubMed ID: 314270
    [Abstract] [Full Text] [Related]

  • 16. Sensitivity of Bacteroides species to modern antimicrobial preparations.
    Závadová M, Tynková S, Adensámová J, Brezinová L.
    J Hyg Epidemiol Microbiol Immunol; 1983 Jun 10; 27(1):51-9. PubMed ID: 6602163
    [Abstract] [Full Text] [Related]

  • 17. Comparison of BL-S786 with cephalothin, cefamandole and cefoxitin in vitro and in treatment of experimental infections in mice.
    Goering RV, Sanders CC, Sanders W.
    J Antibiot (Tokyo); 1978 Apr 10; 31(4):363-72. PubMed ID: 306989
    [Abstract] [Full Text] [Related]

  • 18. In vitro comparison of cefoxitin, cefamandole, cephalexin, and cephalothin.
    Eickhoff TC, Ehret JM.
    Antimicrob Agents Chemother; 1976 Jun 10; 9(6):994-9. PubMed ID: 938029
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.